Interactive visualizer showing how major pharmaceutical mergers and acquisitions relate to clinical trial activity, R&D spending, and market trends over time.
This visualizer brings together clinical trial, financial, and market data to help users examine how large-scale mergers and acquisitions have shaped the pharmaceutical landscape.
By placing major M&A events alongside changes in trial volume, R&D spending, and share price performance, it supports a clearer interpretation of how strategic corporate decisions can influence clinical research activity over time.
Key ways the visualizer supports analysis and learning
Explore M&A timelines in context
Compare clinical trial activity before and after deals
Connect R&D investment and market signals
The visualizer integrates publicly available data from ClinicalTrials.gov, SEC filings, and historical market data sources, covering the period from 2000 to 2022. The visual design emphasizes temporal alignment, allowing users to interpret how clinical, financial, and market indicators move in relation to M&A events rather than drawing causal conclusions.
How do large mergers appear when clinical and financial data are viewed together?
Explore the visual relationships and form your own interpretations based on transparent, referenced data sources.
The eyesON series is Cyntegrity’s collection of interactive data visualizers created to support understanding through transparent, well-structured data exploration. These tools are developed as learning resources, making complex datasets more accessible without oversimplifying them.
Through the eyesON series, Cyntegrity shares its data analytics expertise and regulatory knowledge with the broader research community. Each visualizer transforms dense guidance and datasets into meaningful visual narratives that support learning, cross-functional dialogue, and practical understanding. Explore More Interactive Visualizers…
Interactive visualizer showing how major pharmaceutical mergers and acquisitions relate to clinical trial activity, R&D spending, and market trends over time.
Need a quote, speaker, or more info about Cyntegrity? Reach out directly to our media contact for timely assistance.
Featured Insights
Start Your Roll-Out
Quick Answers